Hone-Blanchet, Antoine
Antal, Botond
McMahon, Liam
Lithen, Andrew
Smith, Nathan A.
Stufflebeam, Steven
Yen, Yi-Fen
Lin, Alexander
Jenkins, Bruce G.
Mujica-Parodi, Lilianne R. http://orcid.org/0000-0002-3752-5519
Ratai, Eva-Maria
Funding for this research was provided by:
W. M. Keck Foundation
Article History
Received: 16 March 2022
Revised: 8 June 2022
Accepted: 10 June 2022
First Online: 22 August 2022
Competing interests
: AH-B, BA, LMcM, APL, SS, NAS, Y-FY, BGJ and LRM-P declare no conflict of interest. APL is a consultant for Agios Pharmaceuticals, Biomarin Pharmaceuticals, and Moncton MRI; is co-founder of BrainSpec Inc.; and receives research funding from NINDS, NIA, the Department of Defense, and the Alzheimer’s Association. E‐MR is a member on the advisory board for BrainSpec, Inc.